Sapphire Clinics

1story
14 Declast updated
Markets & Stocks

Celadon Secures £2M in Funding as It Makes Inaugural Product Delivery, Akanda Appoints New CFO, & Curaleaf Launches on TSX

Celadon Pharmaceuticals [stock_market_widget type=”chart” template=”basic” color=”#5679FF” assets=”CEL.L” range=”1mo” interval=”1d” axes=”true” cursor=”true” range_selector=”true” display_currency_symbol=”true” api=”yf”] Celadon Pharmaceuticals this week passed a ‘significant milestone’ as it completed its first ever supply delivery to clients, just days after the successful completion of a £2m fundraise through a placement of new ordinary shares.

Ben Stevens